Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
Proline-specific endopeptidases
2003
Besedin, D.V.; Rudenskaya, G.N.
Russ. J. Bioorg. Chem.
29
1-17
Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site
2004
Venaelaeinen, J.I.; Juvonen, R.O.; Garcia-Horsman, J.A.; Wallen, E.A.; Christiaans, J.A.; Jarho, E.M.; Gynther, J.; Maennistoe, P.T.
Biochem. J.
382
1003-1008
Purification, identification and characterisation of seprase from bovine serum
2004
Collins, P.J.; McMahon, G.; OBrien, P.; OConnor, B.
Int. J. Biochem. Cell Biol.
36
2320-2333
Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha
2005
Aertgeerts, K.; Levin, I.; Shi, L.; Snell, G.P.; Jennings, A.; Prasad, G.S.; Zhang, Y.; Kraus, M.L.; Salakian, S.; Sridhar, V.; Wijnands, R.; Tennant, M.G.
J. Biol. Chem.
280
19441-19444
Seprase: An overview of an important matrix serine protease
2008
O'Brien, P.; O'Connor, B.F.
Biochim. Biophys. Acta
1784
1130-1145
Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein
2006
Lee, K.N.; Jackson, K.W.; Christiansen, V.J.; Lee, C.S.; Chun, J.; McKee, P.A.
Blood
107
1397-1404
Highly efficient gluten degradation with a newly identified: implications for celiac disease
2006
Stepniak, D.; Spaenij-Dekking, L.; Mitea, C.; Moester, M.; de Ru, A.; Baak-Pablo, R.; van Veelen, P.; Edens, L.; Koning, F.
Am. J. Physiol. Gastrointest. Liver Physiol.
291
G621-G629
Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design
2009
Lee, K.N.; Jackson, K.W.; Terzyan, S.; Christiansen, V.J.; McKee,P.A.
Biochemistry
48
5149-5158
Characterization of membrane-bound prolyl endopeptidase from brain
2008
Tenorio-Laranga, J.; Venaelaeinen, J.I.; Maennistoe, P.T.; Garcia-Horsman, J.A.
FEBS J.
275
4415-4427
Peptidomics of prolyl endopeptidase in the central nervous system
2009
Nolte, W.M.; Tagore, D.M.; Lane, W.S.; Saghatelian, A.
Biochemistry
48
11971-11981
-
Conversion of the anti-tumor agent tasidotin (ILX651) to its active metabolite by prolyl oligopeptidase
2010
Deutch, C.; Krumbholz, R.; Schmid, S.; Bonate, P.; Jurutka, P.
Enzyme Microb. Technol.
46
246-251
Flavonoids with prolyl oligopeptidase inhibitory activity isolated from Scutellaria racemosa Pers
2010
Marques, M.R.; Stueker, C.; Kichik, N.; Tarrago, T.; Giralt, E.; Morel, A.F.; Dalcol, I.I.
Fitoterapia
81
552-6
Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors
2009
Lawandi, J.; Toumieux, S.; Seyer, V.; Campbell, P.; Thielges, S.; Juillerat-Jeanneret, L.; Moitessier, N.
J. Med. Chem.
52
6672-6684
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
2010
Tenorio-Laranga, J.; Coret-Ferrer, F.; Casanova-Estruch, B.; Burgal, M.; Garcia-Horsman, J.A.
J. Neuroinflammation
7
23
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-alpha
2011
Keane, F.; Nadvi, N.; Yao, T.; Gorrell, M.
FEBS J.
278
1316-1332
Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein alpha
2012
Jambunathan, K.; Watson, D.S.; Endsley, A.N.; Kodukula, K.; Galande, A.K.
FEBS Lett.
586
2507-2512
The prolyl peptidases PRCP/PREP regulate IRS-1 stability critical for rapamycin-induced feedback activation of PI3K and AKT
2014
Duan, L.; Ying, G.; Danzer, B.; Perez, R.E.; Shariat-Madar, Z.; Levenson, V.V.; Maki, C.G.
J. Biol. Chem.
289
21694-21705
Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase
2013
Poplawski, S.E.; Lai, J.H.; Li, Y.; Jin, Z.; Liu, Y.; Wu, W.; Wu, Y.; Zhou, Y.; Sudmeier, J.L.; Sanford, D.G.; Bachovchin, W.W.
J. Med. Chem.
56
3467-3477
Prolyl oligopeptidase colocalizes with alpha-synuclein, beta-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinsons and Alzheimers diseases
2013
Hannula, M.J.; Myoehaenen, T.T.; Tenorio-Laranga, J.; Maennistoe, P.T.; Garcia-Horsman, J.A.
Neuroscience
242
140-150
The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma
2019
Bracke, A.; Van Elzen, R.; Van Der Veken, P.; Augustyns, K.; De Meester, I.; Lambeir, A.M.
Clin. Chim. Acta
495
154-160
Prolyl oligopeptidase from the blood fluke Schistosoma mansoni From functional analysis to anti-schistosomal inhibitors
2015
Fajtova, P.; Stefanic, S.; Hradilek, M.; Dvorak, J.; Vondrasek, J.; Jilkova, A.; Ulrychova, L.; McKerrow, J.H.; Caffrey, C.R.; Mares, M.; Horn, M.
PLoS Negl. Trop. Dis.
9
e0003827
BRENDA home
close all tables 
open all tables
top
